To reflect Venzee's new Jasper Business, Venzee proposes to change its name to "JasperX Technologies Inc." in the first quarter of 2026. Venzee's name change will be subject to acceptance by the TSXV ...
The closing of the private placement is expected to occur on or about January 2, 2026, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the ...
CALGARY, Alberta, Dec. 31, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback